Cytek Biosciences Inc (CTKB)

Net profit margin

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020
Net income (ttm)	US$ in thousands	-6,019	-10,159	-17,556	-11,510	-12,148	-14,122	-6,000	-2,210	2,439	-865	-936	2,332	4,592	9,966	14,911	20,352	19,411
Revenue (ttm)	US$ in thousands	176,629	201,210	197,710	200,786	193,014	183,117	175,594	166,060	164,036	154,594	148,493	138,742	127,950	119,675	110,395	99,123	92,839
Net profit margin		-3.41%	-5.05%	-8.88%	-5.73%	-6.29%	-7.71%	-3.42%	-1.33%	1.49%	-0.56%	-0.63%	1.68%	3.59%	8.33%	13.51%	20.53%	20.91%

December 31, 2024 calculation

Net profit margin = Net income (ttm) ÷ Revenue (ttm)
= $-6,019K ÷ $176,629K
= -3.41%

Net profit margin is a key financial ratio that indicates the percentage of each dollar of revenue that results in net profit after all expenses have been deducted.

Analyzing Cytek Biosciences Inc's net profit margin trend reveals fluctuations in the company's profitability over time. From December 31, 2020, to June 30, 2022, the net profit margin showed a consistent decline from 20.91% to -0.63%. This significant decrease suggests a decline in the company's ability to generate profits relative to its revenue.

Subsequently, there was a slight improvement in the net profit margin, reaching 1.49% by December 31, 2022. However, the margin continued to fluctuate with negative values in the following periods, indicating ongoing challenges in maintaining profitability.

By December 31, 2024, the net profit margin improved to -3.41%, but still indicates that the company is facing profitability issues and may need to address cost structure, pricing strategies, or operational efficiency to enhance its bottom line in the future.